Find Gimeracil manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 103766-25-2, Gimestat, 5-chloro-2,4-dihydroxypyridine, 5-chloropyridine-2,4-diol, 5-chloro-4-hydroxy-2(1h)-pyridone, 5-chloro-4-hydroxy-2(1h)-pyridinone
Molecular Formula
C5H4ClNO2
Molecular Weight
145.54  g/mol
InChI Key
ZPLQIPFOCGIIHV-UHFFFAOYSA-N
FDA UNII
UA8SE1325T

Gimeracil
Gimeracil is a pyridine derivative with antitumor activity. Gimeracil enhances the antitumor activity of fluoropyrimidines by competitively and reversibly inhibiting the enzyme dihydropyrimidine dehydrogenase causing decreased degradation of the fluoropyrimidines.
1 2D Structure

Gimeracil

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-chloro-4-hydroxy-1H-pyridin-2-one
2.1.2 InChI
InChI=1S/C5H4ClNO2/c6-3-2-7-5(9)1-4(3)8/h1-2H,(H2,7,8,9)
2.1.3 InChI Key
ZPLQIPFOCGIIHV-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=C(C(=CNC1=O)Cl)O
2.2 Other Identifiers
2.2.1 UNII
UA8SE1325T
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5-chloro-2,4-dihydroxypyridine

2. 5-chloro-4-hydroxy-2(1h)-pyridinone

2.3.2 Depositor-Supplied Synonyms

1. 103766-25-2

2. Gimestat

3. 5-chloro-2,4-dihydroxypyridine

4. 5-chloropyridine-2,4-diol

5. 5-chloro-4-hydroxy-2(1h)-pyridone

6. 5-chloro-4-hydroxy-2(1h)-pyridinone

7. Gimeracil [inn]

8. 5-chloro-4-hydroxy-1h-pyridin-2-one

9. 5-chloro-2,4-pyridinediol

10. 5-chloro-2-hydroxypyridin-4(1h)-one

11. 2(1h)-pyridinone, 5-chloro-4-hydroxy-

12. 5-chloro-4-hydroxy-2-pyridone

13. Ua8se1325t

14. 5-chloro-4-hydroxypyridin-2(1h)-one

15. Mfcd08458352

16. 1349387-07-0

17. Ncgc00181011-01

18. Dsstox_cid_26799

19. Dsstox_rid_81914

20. Dsstox_gsid_46799

21. Cdhp Compound

22. Cas-103766-25-2

23. Unii-ua8se1325t

24. Gimeracil (cdhp)

25. Gimeracil (jan/inn)

26. Gimeracil [jan]

27. Gimeracil [mi]

28. Gimeracil [who-dd]

29. Gimeracil Impurity 1

30. Gimeracil [ema Epar]

31. Schembl124438

32. Ts-1 (tn)

33. Chembl1730601

34. Dtxsid8046799

35. Gimeracil, >=98% (hplc)

36. Chebi:31652

37. Amy2406

38. Teysuno Component Gimeracil

39. Hms3655b15

40. Act04735

41. Bcp05824

42. Tox21_112661

43. Ac-475

44. Stl452964

45. Zinc13831809

46. Gimeracil Component Of Teysuno

47. Akos006346735

48. Akos015891515

49. Akos026749993

50. Tox21_112661_1

51. Bcp9000727

52. Ccg-266172

53. Cs-1822

54. Db09257

55. Ks-5133

56. Ncgc00181011-02

57. Hy-17469

58. Sy029154

59. Ft-0645353

60. S2055

61. Sw219483-1

62. D01846

63. Ab01566858_01

64. 766g252

65. A800802

66. A935098

67. Sr-01000945072

68. Q-100034

69. Sr-01000945072-1

70. Q22075887

2.4 Create Date
2011-12-26
3 Chemical and Physical Properties
Molecular Weight 145.54 g/mol
Molecular Formula C5H4ClNO2
XLogP3-0.1
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count2
Rotatable Bond Count0
Exact Mass144.9930561 g/mol
Monoisotopic Mass144.9930561 g/mol
Topological Polar Surface Area49.3 Ų
Heavy Atom Count9
Formal Charge0
Complexity207
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Gimeracil is used as an adjunct to antineoplastic therapy. When used within the product Teysuno, gimeracil is indicated for the treatment of adults with advanced gastric (stomach) cancer when given in combination with cisplatin.


5 Pharmacology and Biochemistry
5.1 Absorption, Distribution and Excretion

Absorption

Mean 5-FU maximum plasma concentration (Cmax) and area under the concentration-time curve (AUC) values were approximately 3-fold higher after Teysuno administration than after administration of tegafur alone, despite a 16-fold lower Teysuno dose (50 mg of tegafur) compared to tegafur alone (800 mg), and are attributed to inhibition of DPD by gimeracil. Maximum plasma uracil concentration was observed at 4 hours, with a return to baseline levels within approximately 48 hours after dosing, indicating the reversibility of the DPD inhibition by gimeracil. After administration of a single dose of 50 mg Teysuno (expressed as tegafur content), median Tmax for Teysuno components tegafur, gimeracil, and oteracil was 0.5, 1.0, and 2.0 hours, respectively.


Route of Elimination

Following a single dose of Teysuno, approximately 3.8% to 4.2% of administered tegafur, 65% to 72% of administered gimeracil, and 3.5% to 3.9% of administered oteracil were excreted unchanged in the urine.


Volume of Distribution

Although no intravenous data are available for Teysuno in humans, the volume of distribution could be roughly estimated from the apparent volume of distribution and urinary excretion data as 16 l/m2, 17 l/m2, and 23 l/m2 for tegafur, gimeracil and oteracil, respectively.


5.2 Biological Half-Life

Following a single dose of Teysuno, T1/2 values ranged from 6.7 to 11.3 hours for tegafur, from 3.1 to 4.1 hours for gimeracil, and from 1.8 to 9.5 hours for oteracil.


5.3 Mechanism of Action

Gimeracil's main role within Teysuno is to prevent the breakdown of [DB00544] (5-FU), which helps to maintin high enough concentrations for sustained effect against cancer cells. It functions by reversibly blocking the enzyme dihydropyrimidine dehydrogenase (DPD), which is involved in the degradation of 5-FU.


Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Gimeracil Manufacturers

A Gimeracil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gimeracil, including repackagers and relabelers. The FDA regulates Gimeracil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gimeracil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Gimeracil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Gimeracil Suppliers

A Gimeracil supplier is an individual or a company that provides Gimeracil active pharmaceutical ingredient (API) or Gimeracil finished formulations upon request. The Gimeracil suppliers may include Gimeracil API manufacturers, exporters, distributors and traders.

click here to find a list of Gimeracil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Gimeracil USDMF

A Gimeracil DMF (Drug Master File) is a document detailing the whole manufacturing process of Gimeracil active pharmaceutical ingredient (API) in detail. Different forms of Gimeracil DMFs exist exist since differing nations have different regulations, such as Gimeracil USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Gimeracil DMF submitted to regulatory agencies in the US is known as a USDMF. Gimeracil USDMF includes data on Gimeracil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Gimeracil USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Gimeracil suppliers with USDMF on PharmaCompass.

Gimeracil KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Gimeracil Drug Master File in Korea (Gimeracil KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Gimeracil. The MFDS reviews the Gimeracil KDMF as part of the drug registration process and uses the information provided in the Gimeracil KDMF to evaluate the safety and efficacy of the drug.

After submitting a Gimeracil KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Gimeracil API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Gimeracil suppliers with KDMF on PharmaCompass.

Gimeracil GMP

Gimeracil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Gimeracil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gimeracil GMP manufacturer or Gimeracil GMP API supplier for your needs.

Gimeracil CoA

A Gimeracil CoA (Certificate of Analysis) is a formal document that attests to Gimeracil's compliance with Gimeracil specifications and serves as a tool for batch-level quality control.

Gimeracil CoA mostly includes findings from lab analyses of a specific batch. For each Gimeracil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Gimeracil may be tested according to a variety of international standards, such as European Pharmacopoeia (Gimeracil EP), Gimeracil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gimeracil USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty